KRISTY FAYNE: Open Payments
NPI 1174049530 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 9 payments from 8 companies in 2025. Trend: 2023 $363 · 2024 $302 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $144 |
| Teva Pharmaceuticals USA, Inc. | 1 | $95 |
| Verastem, Inc. | 1 | $35 |
| Caris MPI, Inc. | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Eisai Inc. | 1 | $19 |
| Corcept Therapeutics | 1 | $18 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: JEMPERLI, AUSTEDO XR, AVMAPKI FAKZYNJA CO-PACK, MI CANCER SEEK, KEYTRUDA, Lenvima, Korlym, JOURNAVX.
Industry payments across TN — which companies pay providers there.
